| abstract |
Invention, CNS-sedative, trans-5-chloro-2,3,3a, 12b-tetrahydro-2-methyl-1H-dibenz [2,3: 6,7] oxepino [4,5-c] a salt of pyrrole and is a salt-forming agent, the second is an aromatic sulfonic acid. The described salt, preferably besylate, has suitable properties. That is, besylate has the desired insolubility and crystallization properties that may be suitable for use in depot injection preparations. |